These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37227658)

  • 21. Pre-implementation adaptation of primary care cancer prevention clinical decision support in a predominantly rural healthcare system.
    Harry ML; Saman DM; Truitt AR; Allen CI; Walton KM; O'Connor PJ; Ekstrom HL; Sperl-Hillen JM; Bianco JA; Elliott TE
    BMC Med Inform Decis Mak; 2020 Jun; 20(1):117. PubMed ID: 32576202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experiences of three states implementing the Medicaid health home model to address opioid use disorder-Case studies in Maryland, Rhode Island, and Vermont.
    Clemans-Cope L; Wishner JB; Allen EH; Lallemand N; Epstein M; Spillman BC
    J Subst Abuse Treat; 2017 Dec; 83():27-35. PubMed ID: 29129193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of an Implementation Support Intervention on Barriers and Facilitators to Delivery of a Substance Use Prevention Program.
    Cannon JS; Gilbert M; Ebener P; Malone PS; Reardon CM; Acosta J; Chinman M
    Prev Sci; 2019 Nov; 20(8):1200-1210. PubMed ID: 31473932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective.
    Jiao S; Bungay V; Jenkins E; Gagnon M
    Harm Reduct J; 2023 Sep; 20(1):139. PubMed ID: 37735432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying barriers and facilitators for implementing harm reduction strategies for methamphetamine use into hospital settings.
    Forchuk C; Serrato J; Scott L
    Front Health Serv; 2023; 3():1113891. PubMed ID: 36926504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of a Substance Use Recovery Support Mobile Phone App in Community Settings: Qualitative Study of Clinician and Staff Perspectives of Facilitators and Barriers.
    Lord S; Moore SK; Ramsey A; Dinauer S; Johnson K
    JMIR Ment Health; 2016 Jun; 3(2):e24. PubMed ID: 27352884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of a women's reproductive behavioral health telemedicine program: a qualitative study of barriers and facilitators in obstetric and pediatric clinics.
    Sterba KR; Johnson EE; Douglas E; Aujla R; Boyars L; Kruis R; Verdin R; Grater R; King K; Ford D; Guille C
    BMC Pregnancy Childbirth; 2023 Mar; 23(1):167. PubMed ID: 36906564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers and facilitators to implementation of VA home-based primary care on American Indian reservations: a qualitative multi-case study.
    Kramer BJ; Cote SD; Lee DI; Creekmur B; Saliba D
    Implement Sci; 2017 Sep; 12(1):109. PubMed ID: 28865474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facilitators and barriers of sociodemographic data collection in Canadian health care settings: a multisite case study evaluation.
    Williams-Roberts H; Neudorf C; Abonyi S; Cushon J; Muhajarine N
    Int J Equity Health; 2018 Dec; 17(1):186. PubMed ID: 30591045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers to and facilitators of successful implementation of a palliative approach to care in primary care practices: a mixed methods study.
    Langley J; Urquhart R; Tschupruk C; Christian E; Warner G
    BMJ Open; 2024 Jan; 14(1):e079234. PubMed ID: 38296276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different factors identified by stakeholder group for barriers and facilitators to measurement-based care implementation in behavioral health clinics.
    Yule AM; Youn SJ; Dean K; Woodward DW; Firmin ES; Kramer J; Stone M; Marques L; Wilens TE
    J Clin Psychol; 2024 Mar; 80(3):576-590. PubMed ID: 38230918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient and provider perspectives on implementation barriers and facilitators of an integrated opioid treatment and HIV care intervention.
    Cooke A; Saleem H; Hassan S; Mushi D; Mbwambo J; Lambdin B
    Addict Sci Clin Pract; 2019 Jan; 14(1):3. PubMed ID: 30691511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facilitators, barriers and potential solutions to the integration of depression and non-communicable diseases (NCDs) care in Malawi: a qualitative study with service providers.
    Zimba CC; Akiba CF; Matewere M; Thom A; Udedi M; Masiye JK; Kulisewa K; Go VF; Hosseinipour MC; Gaynes BN; Pence BW
    Int J Ment Health Syst; 2021 Jun; 15(1):59. PubMed ID: 34116699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers and facilitators to collaborative care implementation within the New York State Collaborative Care Medicaid Program.
    LePoire E; Joseph M; Heald A; Gadbois D; Jones A; Russo J; Bowen DJ
    BMC Health Serv Res; 2024 Apr; 24(1):505. PubMed ID: 38654291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance use care innovations during COVID-19: barriers and facilitators to the provision of safer supply at a toronto COVID-19 isolation and recovery site.
    Kolla G; Tarannum CN; Fajber K; Worku F; Norris K; Long C; Fagundes R; Rucchetto A; Hannan E; Kikot R; Klaiman M; Firestone M; Bayoumi A; Laurence G; Hayman K
    Harm Reduct J; 2024 Jan; 21(1):17. PubMed ID: 38243267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tracking the randomized rollout of a Veterans Affairs opioid risk management tool: A multi-method implementation evaluation using the Consolidated Framework for Implementation Research (CFIR).
    McCarthy SA; Chinman M; Rogal SS; Klima G; Hausmann LRM; Mor MK; Shah M; Hale JA; Zhang H; Gordon AJ; Gellad WF
    Implement Res Pract; 2022; 3():26334895221114665. PubMed ID: 37091078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.
    Boucher LM; Marshall Z; Martin A; Larose-Hébert K; Flynn JV; Lalonde C; Pineau D; Bigelow J; Rose T; Chase R; Boyd R; Tyndall M; Kendall C
    Harm Reduct J; 2017 May; 14(1):18. PubMed ID: 28494774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formative evaluation and adaptation of pre-and early implementation of diabetes shared medical appointments to maximize sustainability and adoption.
    Kowalski CP; Veeser M; Heisler M
    BMC Fam Pract; 2018 Jul; 19(1):109. PubMed ID: 29981568
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.